A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo, Oxford University said.

L'Université d'Oxford annonce avoir injecté un premier patient avec un vaccin expérimental contre le variant Bundibugyo qui sévit en RDC.

The University of Oxford has already vaccinated its first clinical-trial participant. The study’s lead scientist Teresa Lambe tells Nature how they were able to move so fast.